Recent News

• 09.15.2025 - Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
• 09.15.2025 - Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
• 09.08.2025 - Alterity Therapeutics Raises A$20.0 million in Strategic Placement
• 09.07.2025 - Alterity Therapeutics Raises A$20.0 million in Strategic Placement
• 09.02.2025 - Alterity Therapeutics to Present at the Biotech Showcase
• 09.02.2025 - XBRL 30 June 2025 filed with the SEC

Recent Filings

• 09.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.15.2025 - EX-99.1 EX-99.1
• 09.15.2025 - EX-99.1 EX-99.1
• 09.15.2025 - EX-99.1 EX-99.1
• 09.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.08.2025 - EX-99.1 EX-99.1
• 09.08.2025 - EX-99.1 EX-99.1
• 09.08.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]